Comparison of Cytokine Profile between Postmenopausal Women with and Without Osteoporosis - A Case-Control Study

Endocr Metab Immune Disord Drug Targets. 2023;23(6):811-817. doi: 10.2174/1871530323666221114111029.

Abstract

Background: Chronic low-grade inflammation is involved in the pathogenesis of postmenopausal osteoporosis, but the cytokines implicated remain elusive.

Objective: This study aimed to compare the difference in cytokine profile between postmenopausal women with and without osteoporosis in Klang Valley, Malaysia.

Methods: Postmenopausal women with (n = 20) and without osteoporosis (n = 20) were recruited for this study. Their bone health status was determined using dual-energy X-ray absorptiometry. Their fasting blood was collected for proteomic analysis. A protein array was performed for four subjects randomly selected from each group to screen the potential cytokines. Three cytokines at least 20% different between groups and consistently expressed by each subject were selected for validation using enzyme-linked immunosorbent assays (ELISA).

Results: The protein array screening demonstrated that platelet-derived growth factor-BB, interleukin- 6 receptor (IL-6R), and tissue inhibitor of metallopeptidase-2 were higher in women with osteoporosis than women without osteoporosis (n = 4 per group), and consistently expressed by all women. Only body mass index (BMI)-adjusted logarithmically transformed IL-6R levels were lower among postmenopausal women with osteoporosis compared to women with normal bone health (p = 0.026) (n = 16 per group) in the ELISA test.

Conclusion: IL-6R was lower among postmenopausal women with osteoporosis compared to women with normal bone health after adjusting for BMI. However, a large-scale epidemiological study with proteomic analysis needs to confirm the findings.

Keywords: Osteopororsis; enzyme-linked immunosorbent assays; inflammation; interleukin-6 receptor; platelet-derived growth factor-BB; tissue inhibitor of metallopeptidase- 2.

MeSH terms

  • Bone Density
  • Case-Control Studies
  • Cytokines / metabolism
  • Female
  • Humans
  • Osteoporosis*
  • Osteoporosis, Postmenopausal* / diagnosis
  • Osteoporosis, Postmenopausal* / epidemiology
  • Postmenopause
  • Proteomics

Substances

  • Cytokines